Details

NameSymbolSector
MANGALAM DRUGS AND ORGANICS LTD.MANGALAMPharmaceuticals
Open
28.91
High
28.91
Low
28.91
Close
28.91
Volume
8614
Exchange
bse
Time
28-Apr-2026

Outlook

Score:

2.5

Rating:

RISKY

Candlestick Pattern

CandlepatternofMangalamDrugsAndOrganicsis
Doji
EstimatedStoplossofMangalamDrugsAndOrganicsis
28.91
MangalamDrugsAndOrganicshasa
Bearishℹ
pattern.
Formationof
Doji
candlepatternindicatesthetrenddirectionofMangalamDrugsAndOrganicsis
Unpredictableℹ
.

Trend

MangalamDrugsAndOrganicsisin
Sideways trendℹ
.
PriceofMangalamDrugsAndOrganicsis
Downℹ
by

4.49

%.
Target
Buy@

25.49

Sell@

37.73

Current@

28.91

Volume

ThetradevolumesofMangalamDrugsAndOrganicshavebecome
Deficientℹ
ThevolumetrendforMangalamDrugsAndOrganicsis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofMangalamDrugsAndOrganicsis

Down

by

88.74

%

Valuation

ThecurrentmarketpriceofMangalamDrugsAndOrganicsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth366crandtotalassetsworth366cr,thebalancesheetofMangalamDrugsAndOrganicsis:
Balancedℹ
.
Cashflow
MangalamDrugsAndOrganicshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 1cr

.Itis
Upℹ
by

150

%.
51.22% i.e. ₹ 42cr earned in operatingℹ
23.17% i.e. ₹ 19cr spent in investingℹ
25.61% i.e. ₹ 21cr spent in financingℹ
0% in otherℹ
MangalamDrugsAndOrganicshas
Insufficientℹ
cashflowbecausethereis

Shortage

of

₹ 2cr

.Itis
Downℹ
by

0

%.
15.79% i.e. ₹ 3cr earned in operatingℹ
57.89% i.e. ₹ 11cr spent in investingℹ
26.32% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
TheincomeofMangalamDrugsAndOrganicsis

₹ 49cr

and

Loss

is:

₹ 7cr

MangalamDrugsAndOrganicsLossesdecreasedby:

46.15

%andIncomeisDownby:

14.04

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 57cr

and

Loss

is:

₹ 13cr

MangalamDrugsAndOrganicsLossesincreasedby:

1300

%andIncomeisDownby:

21.92

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 73cr

and

Loss

is:

₹ 0cr

MangalamDrugsAndOrganicsLossesincreasedby:

100

%andIncomeisDownby:

17.05

%
By using this site you agree to the use of cookies to deliver a better site experience.